Neodymium:yttrium-aluminum-garnet laser prostatectomy
- PMID: 9703309
- DOI: 10.4065/73.8.787
Neodymium:yttrium-aluminum-garnet laser prostatectomy
Abstract
Since 1986, benign prostatic hyperplasia has been treated with lasers, but clinical use was not practical until the right-angled fiber was developed in the early 1990s. The neodymium:yttrium-aluminum-garnet (Nd:YAG) laser is one of four types available for treating the prostate. Laser energy levels can be adjusted to provide coagulation (at lower energy densities) or vaporization (at higher energy densities). In a randomized study of these two techniques, symptom scores were similar at 1-year follow-up, but the peak urinary flow rate was higher and the reoperation rate was lower in the patients who received vaporization treatment. In randomized investigations that have compared laser prostatectomy and transurethral resection of the prostate (TURP), symptom scores and urinary flow rates improved in both groups, but results were somewhat better after TURP. Cumulative data for 3-year follow-up after laser prostatectomy have shown that the improved symptom scores and urinary flow are durable. The major disadvantages with use of Nd:YAG prostatectomy are delayed time to voiding, posttreatment dysuria (which occurs in 15 to 30% of patients), and total cost. Overall, Nd:YAG prostatectomy has both pros and cons. In comparison with TURP, the laser procedure is shorter, has fewer complications, can be done on an outpatient basis, and provides quicker recovery and equivalent results.
Similar articles
-
Prospective multicenter ProLase II clinical trial of neodymium:yttrium-aluminum-garnet laser prostatectomy.Urology. 1997 Jul;50(1):63-5. doi: 10.1016/S0090-4295(97)00117-9. Urology. 1997. PMID: 9218020 Clinical Trial.
-
A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate.Urology. 1995 Sep;46(3):305-10. doi: 10.1016/S0090-4295(99)80211-8. Urology. 1995. PMID: 7544932 Clinical Trial.
-
Laser prostatectomy with the holmium: YAG laser.Tech Urol. 1995 Winter;1(4):217-21. Tech Urol. 1995. PMID: 9118394
-
Critical review of lasers in benign prostatic hyperplasia (BPH).BJU Int. 2011 Apr;107(7):1030-43. doi: 10.1111/j.1464-410X.2010.09954.x. BJU Int. 2011. PMID: 21438974 Review.
-
High-power potassium titanyl phosphate laser vaporization prostatectomy.Mayo Clin Proc. 1998 Aug;73(8):798-801. doi: 10.4065/73.8.798. Mayo Clin Proc. 1998. PMID: 9703311 Review.
Cited by
-
Lasers for median lobe hyperplasia.Curr Urol Rep. 2001 Aug;2(4):306-10. doi: 10.1007/s11934-001-0069-x. Curr Urol Rep. 2001. PMID: 12084257 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous